In response to rapid changes in pharmacy practice models and a changing and evolving health care system that impacting the well-being of the nation’s pharmacists, 85 individuals representing pharmacists and employers from across practice settings, schools and colleges of pharmacy, regulators, accreditors, and professional organizations have agreed to a set of 50 recommendations to address […]
State Provider Status Comes to Texas
Two Texas bills recognizing pharmacists as providers and providing payment for pharmacist services were signed into law at the end of May. Championed by the Texas Pharmacy Association, HB 3441 prohibits insurers from denying reimbursement to pharmacists for services provided within the scope of their license, if those services are covered when provided by a […]
Over 200 Pharmacy Stakeholder Groups Urge Senate Finance to Fix DIR
Over 200 pharmacy stakeholder and patient advocacy groups sent a letter to Senators Chuck Grassley and Ron Wyden, chairman and ranking member of the Senate Finance Committee, urging them to include DIR fee reform in their drug pricing legislation. NASPA, along with NCPA, APhA, and many state pharmacy associations, signed on to the letter. The […]
National Pharmacy Organizations Write Azar Regarding Drug Importation
NASPA, along with the American Pharmacists Association (APhA) and the National Association of Chain Drug Stores (NACDS), wrote U.S. Department of Health and Human Services Secretary Azar this week regarding state prescription drug importation plans. All three organizations oppose the approval of a state drug importation program that meets a lower standard than that set […]
Pharmacy Groups Applaud Bipartisan Effort for DIR Relief
National pharmacy organizations applauded the bipartisan Congressional focus on closing the DIR loophole in the recent Medicare rule. Last week, 105 members of the House of Representatives sent the Trump Administration a letter, and 28 senators sent a similar letter. NASPA, along with National Community Pharmacists Association, National Association of Chain Drug Stores, American Pharmacists […]
Over 100 Organizations Urge Congress to Oppose Importation of Non-FDA Approved Drugs
Over 100 health, patient advocacy, and law enforcement organizations, including NASPA and state pharmacy associations, signed on to a letter sent to President Trump and members of Congress asking them to safeguard patients and protect the secure U.S. prescription drug supply. The letter reminds the president and members of Congress that four previous FDA commissioners […]